107
Participants
Start Date
July 11, 2022
Primary Completion Date
April 12, 2026
Study Completion Date
January 26, 2027
Encorafenib
capsule
Cetuximab
IV
Pembrolizumab
IV
Institut Jules Bordet, Anderlecht
Cliniques universitaires Saint-Luc, Brussels
Rigshospitalet, Copenhagen
Herlev and Gentofte Hospital, Copenhagen
Imelda General Hospital, Bonheiden
Peter MacCallum Cancer Centre, Melbourne
Royal Melbourne Hospital, Parkville
Austin Health, Heidelberg
Vejle Sygehus, Vejle
Aalborg Universitetshospital, Syd, Aalborg
Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia, Candiolo
Fakultni Thomayerova nemocnice, Prague
CHUS - Hospital Clinico Universitario, Santiago de Compostela
Istituto Europeo di Oncologia IRCCS, Milan
ASST Grande Ospedale Metropolitano Niguarda, Milan
Facharztzentrum Eppendorf, Hamburg
Fondazione Poliambulanza Istituto Ospedaliero, Brescia
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Universitario Ramón y Cajal, Madrid
Mount Sinai Cancer Center, Miami Beach
Institut Regional du Cancer de Montpellier - ICM Val d'Aurelle, Montpellier
Istituto Oncologico Veneto IRCCS, Padua
The West Clinic, PLLC dba West Cancer Center, Germantown
Hospital Universitario Virgen Del Rocio, Seville
Ospedale di Guastalla, Guastalla
Arcispedale Santa Maria Nuova, Reggio Emilia
Hospital General Universitario de Valencia, Valencia
Hospital Universitario Miguel Servet, Zaragoza
Azienda Ospedaliero Universitaria Pisana, Pisa
Azienda USL Toscana Nord Ovest_Ospedale Civile di Livorno, Livorno
Centre Hospitalier Universitaire Estaing, Clermont-Ferrand
CHU Estaing, Clermont-Ferrand
IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo
Hôpital Européen Georges Pompidou, Paris
Hôpital Saint Antoine, Paris
MD Anderson Cancer Center, Houston
"Azienda Ospedaliera Universitaria dell'Università Luigi Vanvitelli Piazza Luigi Miraglia, 2 Napoli", Napoli
Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie, Munich
Mayo Clinic Building - Phoenix, Phoenix
Mayo Clinic Hospital, Phoenix
Mayo Clinic, Scottsdale
Keck Hospital of USC, Los Angeles
Keck School of Medicine of USC, Los Angeles
LAC USC Medical Center, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles
USC/Norris Comprehensive Cancer Center / Investigational Drug Services, Los Angeles
USC/Norris Comprehensive Cancer Center, Los Angeles
Keck Hospital of USC Pasadena, Pasadena
The Ottawa Hospital - General Campus, Ottawa
Sunnybrook Health Sciences - Odette Cancer Centre, Toronto
Saskatoon Cancer Center, Saskatoon
Fakultni nemocnice Hradec Kralove, Hradec Králové
Fakultni nemocnice Bulovka, Prague
Policlinico Universitario Monserrato, Monserrato
Maastricht UMC+, Maastricht
Oslo Universitetssykehus Ullevål, Oslo
Przychodnia Lekarska KOMED, Konin
Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza, Brzozów
Narodny onkologicky ustav, Bratislava
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Clínic de Barcelona, Barcelona
Institut Català d'Oncologia - L'Hospitalet, L'Hospitalet de Llobregat
Aberdeen Royal Infirmary, Aberdeen
Heartlands Hospital, Birmingham
Lead Sponsor
Merck Sharp & Dohme LLC
INDUSTRY
Merck KGaA, Darmstadt, Germany
INDUSTRY
Eli Lilly and Company
INDUSTRY
Pfizer
INDUSTRY